Emotion Regulation, Physical Diseases, and Borderline Personality Disorders: Conceptual and Clinical Considerations
Overview
Authors
Affiliations
This perspective paper aims at discussing theoretical principles that could explain how emotion regulation and physical diseases mutually influence each other in the context of borderline personality disorder (BPD). Furthermore, this paper discusses the clinical implications of the functional relationships between emotion regulation, BPD and medical conditions considering dialectical behavior therapy (DBT) as a well-validated therapeutic intervention, which encompasses these issues. The inflexible use of maladaptive emotion regulation strategies (e.g., suppression, experiential avoidance, and rumination) might directly increase the probability of developing physical diseases through a physiological pathway, or indirectly through a behavioral pathway. Some metabolic and chronic medical conditions could significantly impact emotional functioning through biological alterations involved in emotion regulation. Several empirical studies have shown high co-occurrence rates between BPD and several chronic physical diseases, especially ones linked to emotion-based maladaptive behaviors. DBT addresses physical diseases reported by individuals with BPD reducing problematic behaviors functionally associated to emotion dysregulation and identifying physical health as a goal for .
Feelings of Patients Admitted to the Emergency Department.
Pilet C, Tandzi-Tonleu F, Lagarde E, Gil-Jardine C, Galinski M, Lafont S Healthcare (Basel). 2025; 13(5).
PMID: 40077062 PMC: 11899625. DOI: 10.3390/healthcare13050500.
Barnett K, Vasiu F Front Behav Neurosci. 2024; 18:1422361.
PMID: 39416439 PMC: 11480958. DOI: 10.3389/fnbeh.2024.1422361.
Gabarda-Blasco A, Elias A, Mendo-Cullell M, Arenas-Pijoan L, Forne C, Fernandez-Onate D Brain Sci. 2024; 14(3).
PMID: 38539624 PMC: 10968253. DOI: 10.3390/brainsci14030236.
Fonseca-Baeza S, Garcia-Alandete J, Marco J, Perez Rodriguez S, Banos R, Guillen V Front Psychol. 2023; 14:1270379.
PMID: 38054179 PMC: 10694221. DOI: 10.3389/fpsyg.2023.1270379.
Johnston L, Jackson K, Hilton C, Graham Y Obes Sci Pract. 2023; 9(5):538-547.
PMID: 37810523 PMC: 10551119. DOI: 10.1002/osp4.670.